Vodcast All Vodcasts
The Stenova trial: A new treatment option with Ontunisertib in fibrostenosing CD
Added 29. July 2026Florian Rieder from Cleveland Clinic, Cleveland, USA, internationally renowned IBD, intestinal fibrosis expert and principal investigator of the new treatment option with the oral GI-restricted small molecule inhibitor of ALK-5 Ontunisertib in fibrostenosisng CD